Rebirth of England.

Chapter 982: Change of coach?

The biggest event in European political life this year may be the European Parliament election to be held in May, which is an election held every five years.

At that time, voters across the European Union will vote to directly elect 751 members of the European Parliament.

Related to this is the change of leadership of the President of the European Council, the President of the European Commission, the High Representative of the European External Action Service, and the change of NATO Secretary-General.

Europe is currently in the context of a gradual easing of the sovereign debt crisis. As the EU integration process is being "forced" by the crisis and is struggling to move forward, this European Parliament election will have a certain impact on the future political and economic situation in Europe, the development of the EU, and even global international relations.

However, before this, European voters were not very enthusiastic about the EU Parliament elections.

According to relevant data, due to voters' general indifference to European politics, distrust of EU institutions and leaders, and dissatisfaction with their "lack of credibility", "inefficiency", "lack of fairness" and "lack of transparency", the direct election of the European Parliament has been declining in EU member states.

1979年欧盟9个成员国时投票率为62%，1994年12个成员国时降到 56.8%，1999年15个成员国时为49.5%，2004年25个成员国时为45.5%，直到上一次的欧洲议会大选，在2009年，27个成员国的平均投票率仅为43%。

According to relevant forecasts, the possibility of voter turnout in this year's European Parliament election exceeding 50% is still small.

However, what is worrying is that ordinary voters have no interest in voting, but supporters of the far-right forces are eager to try, hoping to use this opportunity to vent their dissatisfaction with EU integration.

Beatrice Borromeo was naturally aware of Barron's attitude. He supported European integration. After all, he had invested a lot of industries in various European countries. European integration would help him take advantage of the unified market of the whole of Europe.

But the reality is that there are still many obstacles to European integration.

The simplest point is that it is difficult to unify the language, which is also the difficulty in promoting many industries in Europe, including the Internet.

Speaking of this, the value of Qin Shihuang's "standard writing and standard wheel gauge" is fully demonstrated.

You can imagine that the EU currently has 27 member states with a total area of ​​about 432.2 million square kilometers, and almost every member state of the EU has its own distinctive language.

That is to say, in this area which is less than half the size of China, there are 24 official languages ​​- this situation is almost equivalent to the fact that China has no standard Mandarin, but each province uses a "dialect" with different pronunciation and writing. Just imagine how chaotic this situation is.

You said the European Union should have a unified language? Then which language should it be? Although English is the most widely used language in the world and can be called the "world language", do we French agree? French has always been the "noble language" of Europe...

And Spanish. English and French are widely used around the world, so how can Spanish be inferior to them? Latin American Spanish is also widely used.

This is not the end. Germany is now the economic locomotive of the European Union. Doesn’t the German language deserve a place?

What's more, with Europe's "democracy" system, how can it be possible to force the unification of language? They don't have a strong central government, and trivial matters can be discussed for years...

After Beatrice Borromeo left England, Barron was finally ready to meet with the GlaxoSmithKline board of directors.

Last year, DS Group, operated by Daisy, shorted GlaxoSmithKline, the largest pharmaceutical company in the UK. Using the profits from this shorting, DS Group then bought some of GlaxoSmithKline's shares...

They currently hold nearly 10% of GlaxoSmithKline's shares and are one of the company's major shareholders.

When DS Group was shorting GlaxoSmithKline, the company was caught up in investigations in China and the United States for commercial bribery. It can be said that GlaxoSmithKline's management had privately "greeted" the other party many times.

However, the situation is stronger than people. DS Group has become a major shareholder of GlaxoSmithKline, and their funds, including the European Wealth Fund which was established not long ago, are continuing to acquire holdings of some institutions. It is believed that they will soon become the largest shareholder of GlaxoSmithKline. In this case, coupled with Baron's power in the West, it would not be wise to continue to oppose this capital tycoon.

"I support GlaxoSmithKline making some changes, gentlemen."

Barron met with GlaxoSmithKline board members at Chatsworth House, well, it looked more like a "reception."

He said to these people:
"I understand that the R&D investment in oncology drugs is huge and carries considerable risks, but I still believe that even if the oncology drug and consumer health products businesses are split, the best way is to form a joint venture with related businesses of other companies, and we retain shares..."

In fact, Andrew Witty, the current CEO of GlaxoSmithKline, views the oncology drug business in this way, believing that it requires huge investment and has a high failure rate. He is considering selling or replacing GlaxoSmithKline's oncology drug business with vaccines or OTC (over-the-counter drug) businesses that he is interested in.

But Baron knew that GlaxoSmithKline, led by Andrew Witty, did not have ideal revenue in the future, which also caused its stock price performance to be inferior to other pharmaceutical giants.

Read more latest popular novels at 6.9*shuba!

Barron doesn't want to wait until a new CEO is needed to adjust GlaxoSmithKline's development path adjusted by Andrew Witty...

Therefore, Andrew Witty's fate was sealed when he decided to become a major shareholder of GlaxoSmithKline.

He could no longer wait until GlaxoSmithKline fell out of the top ten global pharmaceutical companies in 2017 before firing Andrew Witty as he had done in the original time and space.

Although DS Group currently only holds about 10% of GlaxoSmithKline's shares, the funds under its umbrella are still purchasing GlaxoSmithKline shares from other institutions. Compared with last year, GlaxoSmithKline's share price has rebounded a lot, which has also made some institutions want to take this opportunity to "jump ship" and sell their GlaxoSmithKline shares.

Once he becomes a major shareholder of GlaxoSmithKline, he will start contacting other shareholders to replace the CEO.

It seems that Emma Walmsley, who later took over the position of CEO of GlaxoSmithKline in the original time and space, performed well. She is now working for the L'Oréal Group under the GHL Group.

(End of this chapter)